Home/ Supplements/ Alpha Lipoic Acid/ Alpha Lipoic Acid 300 mg

Alpha Lipoic Acid 300 mg

product on market Tablet or Pill Dr. Rico Perez Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 50% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Alpha Lipoic Acid and Riboflavin are studied for their roles in antioxidant support and energy metabolism. Research provides moderate evidence for the use of Alpha Lipoic Acid in managing certain metabolic conditions. Overall evidence coverage for this specific formulation is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Alpha Lipoic Acid 300 mg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Vegetarian Tablet(s)
Serving Size
60
Servings
Other Combinations
Product Type
50%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

12 mg (706% DV)
9.2× RDA — above typical dose 13 studies (A:0, B:1)
Market median: 200.0mg (198 products) 6 studies — no high-quality reviews

Other Ingredients

Tricalcium Phosphate Modified Cellulose Silica Calcium Silicate Magnesium Stearate Dicalcium Phosphate Vegetable Coating
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Suggested use: Take one (1) to two (2) vegetarian tablets daily with meals.

Warnings & Precautions

Note: If you are pregnant, nursing, have a health condition or are taking any medications, consult your health care practitioner before using this product.

Keep out of reach of children.

Formulation Notes

Manufactured in a cGMP certified facility. Freshness Assured

Sustained Release

Additional Information

Store in a cool, dry place.

Made in USA from domestic and foreign materials.

Metadata

Product Details

UPC / SKU8 79840 00082 8
DSLD Entry Date2024-11-22
Product TypeOther Combinations
FormTablet or Pill
DSLD ID321007
Data Updated2026-04-11
Research

Research Evidence

21
Research Sources
52
Avg Quality
13
Rct
4
Meta Analysis
2
Systematic Review
2
Clinical Trial
A Alpha-lipoic acid for diabetic peripheral neuropathy
Systematic Review The Cochrane database of systematic reviews 2024 PubMed DOI
B Efficacy and Safety of the Combination of Palmitoylethanolamide, Superoxide Dismutase, Alpha Lipoic Acid, Vitamins B12, B1, B6, E, Mg, Zn and Nicotinamide for 6 Months in People with Diabetic Neuropathy
Rct Nutrients 2024 PubMed DOI
B Alpha Lipoic Acid Supplementation and Iron Homeostasis: A Comprehensive Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials
Meta Analysis International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition 2024 PubMed DOI
B Effectiveness of alpha-lipoic acid in patients with neuropathic pain associated with type I and type II diabetes mellitus: A systematic review and meta-analysis
Meta Analysis Medicine 2023 PubMed DOI
C The effects of alpha-lipoic acid supplementation on glucose control and lipid profiles among patients with metabolic diseases: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Metabolism: clinical and experimental 2018 PubMed DOI
C A systematic review and meta-analysis of α-lipoic acid in the treatment of diabetic peripheral neuropathy
Meta Analysis European journal of endocrinology 2012 PubMed DOI
C Oral Alpha Lipoic Acid Treatment for Symptomatic Diabetic Peripheral Neuropathy: A Randomized Double-Blinded Placebo-Controlled Study
Rct Endocrine, metabolic & immune disorders drug targets 2020 PubMed DOI
C A randomized, double-blind, placebo controlled study to evaluate the effect of alpha-lipoic acid on inhibition of ADP-and collagen-induced platelet aggregation ex vivo in diabetic neuropathy patients on gabapentin or pregabalin
Rct Journal of postgraduate medicine 2024 PubMed DOI
C Ranking Alpha Lipoic Acid and Gamma Linolenic Acid in Terms of Efficacy and Safety in the Management of Adults With Diabetic Peripheral Neuropathy: A Systematic Review and Network Meta-analysis
Systematic Review Canadian journal of diabetes 2024 PubMed DOI
C Effect analysis of tanshinone IIA sulfonate sodium combined with a-lipoic acid in patients with diabetes peripheral neuropathy.
Rct Pakistan journal of pharmaceutical sciences PubMed
View all evidence for Alpha Lipoic Acid →
Compare

Similar Products

View all Alpha Lipoic Acid products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.